MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Neuroprotection: Where Do We Stand?
Advantages, disadvantages, what we can learn from the most common neuroprotection strategies, and future directions for the field.
By Shahid M. Nimjee, MD, PhD, and Michael D. Hill, MD
ESCAPE and EXTEND-IA Trials Confirm Benefits of Medtronic's Solitaire Flow Restoration Device for Stroke
February 11, 2015—Medtronic, plc announced that two studies presented at the International Stroke Conference in Nashville, Tennessee, and published online in The New England Journal of Medicine found that stent thrombectomy using the company’s Solitaire device added to the current standard of pharmaceutical treatment with intravenous tissue plasminogen activator (IV-tPA) significantly reduced disability in patients experiencing a stroke. Both the ESCAPE (Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke) and the EXTEND-IA (Extending the Time for Thrombolysis in Emergency Neurological Deficits—Intra-Arterial) trials were investigator-initiated trials supported by an unrestricted grant from Medtronic that primarily assessed the addition of the company’s Solitaire device in conjunction with IV-tPA.
Explorations in Neurointervention
By Ashutosh P. Jadhav, MD, PhD
PAD Task Force Urges Passage of ARC Act for Amputation Prevention
December 1, 2020—The CardioVascular Coalition (CVC) announced the publication of an opinion editorial in The Hill calling for lawmakers to support peripheral artery disease (PAD) testing and education to prevent amputations.
The Status of Endovascular Therapy in Australia
By Michael M. D. Lawrence-Brown, MD, and James B. Semmens, MSc, PhD
Postprocedure Intensive Care Management of Stroke Patients
Appropriate postprocedure management improves outcomes in stroke patients.
By Michael T. Froehler, MD, PhD, and Romergryko G. Geocadin, MD
Low-Profile CLI Devices
The latest innovations in outflow treatment devices are expanding options for a growing CLI patient population.
By George L. Adams, MD, MHS, FACC, and Michael J. Pompliano, BS
Thoracic Endograft Performance Evaluations
Insights shared at the 2007 Cleveland Clinic Stent Summit.
By Robert G. Whirley, PhD; Mike Nilson, BS; Catherine Szyman, MBA; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD
2010 Vascular Disease Foundation Awards
Wallaby Medical Acquires German Neurovascular Company Phenox GmbH
April 21, 2022—Wallaby Medical, a company focused on developing and commercializing neurovascular interventional products for treating stroke, announced that it has acquired Germany-based Phenox GmbH, including Phenox’s Femtos GmbH.
Guidelines for the Use of Optional (Retrievable and Convertible) Vena Cava Filters
A summary of the SIR multidisciplinary consensus statement.
By John A. Kaufman, MD
Aggressive DVT Management Strategies and Techniques
Experts share their experiences with early intervention using pharmacomechanical thrombectomy and temporary filter placement, which have shown rapid symptom resolution and encouraging outcomes.
By Mark W. Mewissen, MD; Anthony C. Venbrux, MD; and Peter H. Lin, MD
Ask the Experts: Is 16 F Small Enough? Will < 16 F Be Durable?
Experts discuss the impact of low-profile devices and the challenges to further reducing profile size.
With Michael D. Dake, MD; Jonathan S. Deitch, MD, FACS; Eric L.G. Verhoeven, MD, PhD; and Edward Y. Woo, MD
An Interview With Michael D. Dake, MD
A world leader in endoluminal treatment of aortic disease discusses the evolution of TAA grafting and the Zilver PTX trial.
By Michael D. Dake, MD
The Zilver PTX Global Registry and RCT
Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.
Insights on the DISSECT Classification System
Michael D. Dake, MD, describes the goals, details, and real-world applicability of a modern, mnemonic-based classification system for aortic dissection.
Perspective: Exploring Outpatient EVAR
Pipe dream or reality? With a new generation of low-profile devices emerging, Michael D. Dake, MD, shares his thoughts on the future of taking endovascular aneurysm repair to the outpatient setting.
Sponsored by Cook Medical
Timing of TEVAR Treatment
When should treatment occur in acute, initially uncomplicated type B aortic dissection?
Chronic Cerebrospinal Venous Insufficiency
A new paradigm and therapy for multiple sclerosis.
By Salvatore J.A. Sclafani, MD Commentary by Michael D. Dake, MD, and Barry T. Katzen, MD
